Auven Therapeutics

Auven Therapeutics pits rival PhIII dry eye drug against Allergan, Shire
Fierce Biotech
Fri, 11/13/15 - 11:01 am
Auven Therapeutics
dry eye disease
Seciera
Restasis
Allergan
Shire
Lifitegrast